Biomarker Commercialization

Diagnostic innovation is by far one of the most challenging spaces in which to develop novel commercial concepts. To ease and structure the complex process, a European Consortium has been working on the development of a support framework to guide would-be founders on the technical, regulatory and commercial development of diagnostic/biomarker focused companies.

The framework can be found via: